68Ga-BMV101

N/A

Report date: 2025/11/20 16:01:03
NME

Base Information

Drug Name68Ga-BMV101
Drug Alias NameN/A
ClassificationRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionCysteine proteases modulators
TargetsCysteine proteases
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesPeking Union Medical College HospitalStanford University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPeking Union Medical College HospitalStanford University
Active IndicationsN/A
Inactive IndicationsIdiopathic Pulmonary Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A